Cost-effectiveness and optimal stopping ages for colorectal cancer screening after age 75 years appear to be associated with ...

A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC trial.

2 In contrast, patients of average risk can use any CRC screening test, including the noninvasive mtsDNA test. Stool-based tests are a helpful option in locations where colonoscopy services are ...

Fecal tests emerged as the most effective and cost-effective colorectal cancer screening strategy, yielding 121 life years gained per 1,000 screened individuals and a net monetary benefit of $5,883 ...

Negative colonoscopy screening results were linked to lower long-term CRC incidence and mortality. These findings support extending the 10-year recommended rescreening interval for those at low ...

The combination treatment specifically targets KRAS-mutated metastatic colorectal cancer (CRC) to improve progression-free survival. The approval was based on results from CodeBreaK 300 ...

The findings reveal that in triaging FIT-positive patients in CRC screening, the QuantiDNA™ test from patients' plasma reduces the need for colonoscopy examinations by 33% and is non-inferior to ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Participants were males and females, 50 years and above, with no prior history of CRC screening ... needed to carefully consider all response options before describing experiences.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.